DEF 14A

Company

FILANA THERAPEUTICS, INC.

Filed

March 26, 2020

Period of Report

March 26, 2020

Accession Number

0001069530-20-000011

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →